BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32440915)

  • 1. Latest progress in molecular biology and treatment in genitourinary tumours.
    González-Del-Alba A; Arranz JÁ; Bellmunt J; Maroto JP; Fernández-Calvo O; Valderrama BP; González-Billalabeitia E; Méndez-Vidal MJ; Cassinello J; Romero-Laorden N; Climent MÁ; Puente J; Peláez I; Lázaro-Quintela M; Gallardo E; Suárez C
    Clin Transl Oncol; 2020 Dec; 22(12):2175-2195. PubMed ID: 32440915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
    [No Abstract]   [Full Text] [Related]  

  • 3. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel immunotherapies in GU malignancies.
    Drakaki A; McDermott DF
    Curr Oncol Rep; 2013 Jun; 15(3):224-31. PubMed ID: 23519772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bigot F; Bonnet C; Massard C
    Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targetable gene fusions and aberrations in genitourinary oncology.
    Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
    Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genitourinary cancer.
    Hudes GR; Ozols RF; Schilder RJ
    Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
    [No Abstract]   [Full Text] [Related]  

  • 8. Harnessing Natural Killer Cell Function for Genitourinary Cancers.
    Bhardwaj N; Farkas AM; Gul Z; Sfakianos JP
    Urol Clin North Am; 2020 Nov; 47(4):433-442. PubMed ID: 33008494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genitourinary malignancy.
    Leighton J; Clark J; Giantonio B; Ozols R; Hudes G
    Cancer Chemother Biol Response Modif; 1996; 16():524-63. PubMed ID: 8639400
    [No Abstract]   [Full Text] [Related]  

  • 10. [DGFIT: Immune and targeted therapy in urologic oncology – what can be expected?].
    Hegele A; Heinzer H; Rüttinger D; Siebels M
    Aktuelle Urol; 2012 Jul; 43(4):219-26. PubMed ID: 23035262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of RNA interference as therapeutic strategy in urologic cancer.
    Green WJ; James PA; Ratan HL
    Urology; 2011 Sep; 78(3):500-4. PubMed ID: 21741681
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy in genitourinary malignancies.
    Wattenberg MM; Fong L; Madan RA; Gulley JL
    Curr Opin Urol; 2016 Nov; 26(6):501-7. PubMed ID: 27471994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL-mediated signaling in prostate, bladder and renal cancer.
    Voelkel-Johnson C
    Nat Rev Urol; 2011 Jun; 8(8):417-27. PubMed ID: 21670755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination immunotherapy in genitourinary malignancies.
    Hoffman-Censits J; Wilde L
    Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urological malignancy in Hong Kong: the trend and the practice.
    Yee CH; Ng CF
    Jpn J Clin Oncol; 2015 Dec; 45(12):1103-6. PubMed ID: 26450701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy in uropathology].
    Verkarre V; Roussel H; Granier C; Tartour E; Allory Y
    Ann Pathol; 2017 Feb; 37(1):90-100. PubMed ID: 28111042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treating scenario in genitourinary oncology: what is new? Part 2.
    Bracarda S; Montironi R; Porta C; Szczylic C; Bearz A; Cartenì G; Bellmunt J
    Future Oncol; 2013 Jun; 9(6):803-6. PubMed ID: 23718300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Towards the individualisation of prescriptions in oncology: urogenital cancers].
    Pouessel D; Culine S
    Bull Cancer; 2008 Oct; 95(10):975-8. PubMed ID: 19004728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
    Small EJ; Halabi S; Kantoff P; D'Amico A; Stadler W; Kelley WK; Mohler J; Bajorin D; Vogelzang NJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3596s-600s. PubMed ID: 16740791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genitourinary cancer.
    Hudes GR; Grana G; Deshields MS; Ozols RF
    Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.